World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
9919
World Ranking
11611
National Ranking
4996

Overview

Philip M. Potter is affiliated with St. Jude Children's Research Hospital in the United States. Their research spans several fields, primarily focusing on biochemistry, genetics, molecular biology, and medicine. This multidisciplinary approach supports investigations into molecular biology, pharmacology, computational theory and mathematics, biomaterials, and hematology.

The scientist's work prominently addresses topics related to cholinesterase and neurodegenerative diseases, computational drug discovery methods, nanoparticle-based drug delivery, protein degradation and inhibitors, multiple myeloma research and treatments, ubiquitin and proteasome pathways, as well as enzyme function and inhibition.

Frequent coauthors contributing to their publications include Matthew R. Redinbo, Lyudmila Tsurkan, Sompop Bencharit, Peter Kühn, and Markos Leggas.

Their research output has been published mainly in UNC Libraries and Cancer Research, reflecting a breadth of scholarly communications in these venues.

  • Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer, 2020, Cancer Research
  • Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: From binding promiscuity to selective inhibition, 2021, UNC Libraries
  • High Payload Dual Therapeutic-Imaging Nanocarriers for Triggered Tumor Delivery, 2020, UNC Libraries
  • Nanoparticles Containing Anti-inflammatory Agents as Chemotherapy Adjuvants II: Role of Plasma Esterases in Drug Release, 2020, UNC Libraries
  • Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme, 2020, UNC Libraries

Best Publications

  • Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma

    Xiang Chen;Elizabeth Stewart;Anang A. Shelat;Chunxu Qu

  • Mammalian carboxylesterases: from drug targets to protein therapeutics.

    Matthew R. Redinbo;Philip M. Potter

  • Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme.

    Sompop Bencharit;Christopher L Morton;Yu Xue;Philip M Potter

  • Hydrolysis of pyrethroids by human and rat tissues: Examination of intestinal, liver and serum carboxylesterases

    J. Allen Crow;Abdolsamad Borazjani;Philip M. Potter;Matthew K. Ross

  • Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing.

    Liying Fan;Chandraiah Lagisetti;Carol C. Edwards;Thomas R. Webb

  • Proficient metabolism of irinotecan by a human intestinal carboxylesterase.

    Ruchi Khanna;Christopher L. Morton;Mary K. Danks;Philip M. Potter

  • Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases.

    Matthew K. Ross;Abdolsamad Borazjani;Carol C. Edwards;Philip M. Potter

  • Structural insights into CPT-11 activation by mammalian carboxylesterases.

    Sompop Bencharit;Christopher L. Morton;Escher L. Howard-Williams;Mary K. Danks

  • Characterisation and nucleotide sequence of ogt, the O6-alkylguanine-DNA-alkyltransferase gene of E. coli.

    P M Potter;M C Wilkinson;J Fitton;Francis J Carr

  • Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene

    Linda C. Harris;Philip M. Potter;Keizo Tano;Susumu Shiota

  • Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition.

    Sompop Bencharit;Christopher L Morton;Janice L Hyatt;Peter Kuhn

  • Identification and Characterization of Novel Benzil (Diphenylethane-1,2-dione) Analogues as Inhibitors of Mammalian Carboxylesterases

    Randy M. Wadkins;Janice L. Hyatt;Xin Wei;Kyoung Jin P. Yoon

  • Carboxylesterases - Detoxifying Enzymes and Targets for Drug Therapy

    Philip M Potter;Randy M Wadkins

  • Targeting the DNA repair pathway in Ewing sarcoma

    Elizabeth Stewart;Ross Goshorn;Cori Bradley;Lyra M. Griffiths

  • Tumor-Targeted Enzyme/Prodrug Therapy Mediates Long-term Disease-Free Survival of Mice Bearing Disseminated Neuroblastoma

    Mary K. Danks;K. Jin Yoon;Rebecca A. Bush;Joanna S. Remack

  • Carboxylesterases: General detoxifying enzymes.

    M. Jason Hatfield;Robyn A. Umans;Janice L. Hyatt;Carol C. Edwards

  • Multisite Promiscuity in the Processing of Endogenous Substrates by Human Carboxylesterase 1

    Sompop Bencharit;Carol C. Edwards;Christopher L. Morton;Escher L. Howard-Williams

  • Human carboxylesterase 1: from drug metabolism to drug discovery.

    M.R. Redinbo;S. Bencharit;P.M. Potter

  • Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil.

    Christopher D. Fleming;Sompop Bencharit;Carol C. Edwards;Janice L. Hyatt

  • Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy.

    Mary K. Danks;Christopher L. Morton;Erik J. Krull;Pamela J. Cheshire

Frequent Co-Authors

Mary K. Danks
Mary K. Danks St. Jude Children's Research Hospital
Matthew R. Redinbo
Matthew R. Redinbo University of North Carolina at Chapel Hill
Geoffrey P. Margison
Geoffrey P. Margison University of Manchester
Richard E. Lee
Richard E. Lee St. Jude Children's Research Hospital
Gang Wu
Gang Wu Washington University in St. Louis
John Easton
John Easton St. Jude Children's Research Hospital
Peter J. Houghton
Peter J. Houghton The University of Texas Health Science Center at San Antonio
Jinghui Zhang
Jinghui Zhang St. Jude Children's Research Hospital
Seung U. Kim
Seung U. Kim University of British Columbia
Michael A. Dyer
Michael A. Dyer St. Jude Children's Research Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Philip M. Potter

Trending Scientists

Recently Published Articles